GTR is a multi-disciplinary consulting, research, and analytics group focusing on legal hemp and biotechnology markets.
DATA - DRIVEN ANALYSIS
GTR provides investors with unique opportunities in the hemp and related biotechnology and healthcare spaces; accomplishing this through deep domain knowledge, including extensive due diligence on legally compliant markets for cannabis-related products and services.
The GTR management team has been investing in the hemp space since 2016, and has conducted an unparalled amount of deep valuation analysis across the sector.
GTR's multidisciplinary team is made up of proven experts in the fields of portfolio management, law, genetics, bio-medicine, agriculture, and technology.
GTR’s deep scientific and technical knowledge assures clients that the firm identifies the most compelling opportunities in the hemp market especially pertaining to newly discovered properties of the plant, which are accelerating legally compliant investment opportunities.